nGageIT Digital Health invited to participate in New York Healthcare Innovation Day

PRESS RELEASE: Toronto, Canada

nGageIT Digital Health will be attending PlugandPlay’s New York Healthcare Innovation Day on October 24th, 2019 from 1pm to 5pm. 

Join high-level executives and us for an intimate discussion around integrating startups and new technologies into mature healthcare business divisions. We will be facilitating a conversation with executives and startup founders on sharing lessons learned from real examples and how success stories happened.

This intimate forum will leave participants with a stronger network of New York’s healthcare leaders, and specific knowledge on how to successfully integrate startup innovation to meet their objectives.

If you are interested in meeting with us while we are here please email us at events@ngageittec.com.

nGageIT is a world leader in developing rapid real time breath testing at the point of care based in Toronto.  The company specialises in creating integrated real time rapid breath diagnostic test (RBDT) platforms for breath-based testing of cancer and inflammatory disease.  The recipient of multiple awards for innovation, nGageITs all-in-one Airostotle ™ handheld devices make it easy to test and screen for a range of diseases such as cancer and chronic inflammatory diseases.  Unlike standard, multi-component blood tests, Airostotle ™ platforms integrate features and deliver an easy to use non-invasive breath test with results in real time at the point of care without the need to ship out samples.
Early non-invasive detection of lung cancer, the leading cause of cancer-related death has tremendous societal and financial value. Lung cancer cells generate and out-gas unique volatiles that exit the body through breath, providing an olfactory signature.  nGageIT is developing a breath analysis system that enables a completely non-invasive, low cost diagnosis of lung cancer. Using nGageIT’s Airostotle breath sensor system the company has completed a study showing high accuracy screening of lung cancer from breath compared to health patients. Further larger trials are planned to resolve sub-stratification of the disease.
As well as commercializing products in its own brand, nGageIT is developing strategic partnerships to provide OEM product development services to specialist diagnostic companies worldwide.
To find out more, visit: http:/www.ngageittec.com.